STAT3 and osteosarcoma: It has been shown that DLGAP5 can activate interleukin-6/Janus kinase 2/signal transducer and activator of transcription 3 (IL-6/JAK2/STAT3) signaling pathway thereby promoting the proliferation and invasion of osteosarcoma cells [41].